NCT03232905View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

October 27, 2017

Study Completion Date

November 22, 2017

Conditions
Healthy
Interventions
DRUG

PF-06651600

PF-06651600 will be administered as tablet

DRUG

Placebo

Matching placebo will be administered as tablet

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03232905 - Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers | Biotech Hunter | Biotech Hunter